Dexmedetomidine Attenuates Inflammation in Elderly Patients Following Major Hepatobiliary and Pancreatic Surgery: A Randomized Clinical Trial

Xingtong Chen,Qian Chen,Zhigang Qin,Azeem Alam,Hailin Zhao,Raha West,Xianzhe Liu,Jieyu Li,Xin Li,Bin Yi,Daqing Ma,Jianteng Gu

DOI: https://doi.org/10.2147/cia.s455987

IF: 3.829

2024-05-29

Clinical Interventions in Aging

Abstract:Xingtong Chen, 1, &ast Qian Chen, 1– 3, &ast Zhigang Qin, 1, &ast Azeem Alam, 3 Hailin Zhao, 3 Raha West, 3 Xianzhe Liu, 1 Jieyu Li, 1 Xin Li, 1 Bin Yi, 1 Daqing Ma, 2, 3 Jianteng Gu 1 1 Department of Anesthesiology, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, People's Republic of China; 2 Perioperative and Systems Medicine Laboratory, National Clinical Research Center for Child Health, Children's Hospital, Zhejiang University School of Medicine, Zhejiang, People's Republic of China; 3 Division of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Chelsea & Westminster Hospital, London, UK &astThese authors contributed equally to this work Correspondence: Jianteng Gu, Department of Anesthesiology, Southwest Hospital, Third Military Medical University (Army Medical University), 30 Gaotanyan Road, Chongqing, 400038, People's Republic of China, Tel +86 23 68766122, Fax +86 23 65463270, Email Daqing Ma, Division of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Chelsea & Westminster Hospital, London, UK, Email Background: Dexmedetomidine (Dex) may have anti-inflammatory properties and potentially reduce the incidence of postoperative organ injury. Objective: To investigate whether Dex protects pulmonary and renal function via its anti-inflammatory effects in elderly patients undergoing prolonged major hepatobiliary and pancreatic surgery. Design and Setting: Between October 2019 and December 2020, this randomized controlled trial was carried out at a tertiary hospital in Chongqing, China. Patients: 86 patients aged 60– 75 who underwent long-duration (> 4 hrs) hepatobiliary and pancreatic surgery without significant comorbidities were enrolled and randomly assigned into two groups at a 1:1 ratio. Interventions: Patients were given either Dex or an equivalent volume of 0.9% saline (Placebo) with a loading dose of 1 μg kg − 1 for 10 min, followed by 0.5 μg kg − 1 hr − 1 for maintenance until the end of surgery. Main Outcome Measures: The changes in serum concentrations of interleukin-6 (IL-6) and tumour necrosis factor-α (TNF-α) were primary outcomes. Results: At one hour postoperatively, serum IL-6 displayed a nine-fold increase (P< 0.05) in the Placebo group. Administration of Dex decreased IL-6 to 278.09 ± 45.43 pg/mL (95% CI: 187.75 to 368.43) compared to the Placebo group (P=0.019; 432.16 ± 45.43 pg/mL, 95% CI: 341.82 to 522.50). However, no significant differences in TNF-α were observed between the two groups. The incidence of postoperative acute kidney injury was twice as high in the Placebo group (9.30%) compared to the Dex group (4.65%), and the incidence of postoperative acute lung injury was 23.26% in the Dex group, lower than that in the Placebo group (30.23%), although there was no statistical significance between the two groups. Conclusion: Dex administration in elderly patients undergoing major hepatobiliary and pancreatic surgery reduces inflammation and potentially protects kidneys and lungs. Registration: Chinese Clinical Trials Registry, identifier: ChiCTR1900024162, on 28 June 2019. Keywords: dexmedetomidine, elderly patients, long-duration hepatobiliary and pancreatic laparotomy, perioperative renal function, perioperative pulmonary function There is a growing trend in the number of surgical procedures being performed on elderly patients 1 and advancing age is associated with a high risk of perioperative complications. 2,3 It has been reported that the perioperative mortality rate in elderly patients is 4.4 times greater than that observed in young and middle-aged patients. 4,5 Notably, long-duration surgeries such as hepatobiliary and pancreatic surgery in elderly patients have a high risk of iatrogenic trauma and ischemia-reperfusion injury (IRI). 6 IRI produces inflammatory cytokines and damage-associated molecular pattern proteins (DAMPs), potentially leading to renal and pulmonary dysfunction postoperatively. This, in turn, results in prolonged hospital stays, elevated medical costs, and increased postoperative mortality. 7 Dexmedetomidine (Dex) acts on α 2 -adrenergic receptors in the nucleus locus coeruleus, suppressing the sympathetic nervous system while stimulating the vagus nerv -Abstract Truncated-

geriatrics & gerontology,gerontology